These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28396656)

  • 1. Prescription Patterns for Tigecycline in Severely Ill Patients for Non-FDA Approved Indications in a Developing Country: A Compromised Outcome.
    Moghnieh RA; Abdallah DI; Fawaz IA; Hamandi T; Kassem M; El-Rajab N; Jisr T; Mugharbil A; Droubi N; Al Tabah S; Sinno L; Ziade F; Daoud Z; Ibrahim A
    Front Microbiol; 2017; 8():497. PubMed ID: 28396656
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients.
    Kuo SC; Wang FD; Fung CP; Chen LY; Chen SJ; Chiang MC; Hsu SF; Liu CY
    J Microbiol Immunol Infect; 2011 Feb; 44(1):45-51. PubMed ID: 21531352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline treatment of critically ill patients: the LatinUser experience.
    Curcio D; Vargas SW; Ugarte Ubiergo S; Varón F; Rojas Suarez J; Paz Chávez C; Curiale A;
    Curr Clin Pharmacol; 2011 Feb; 6(1):18-25. PubMed ID: 21235466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tigecycline Utilization and Trends in Antibacterial Resistance from 2018 to 2021 in a Comprehensive Teaching Hospital in China.
    Zhou H; Sun X; Lyu S; Yu X; Li R; Wang H; An Z
    Infect Drug Resist; 2023; 16():879-889. PubMed ID: 36820081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an antibiotic stewardship program on tigecycline use in a Tertiary Care Hospital, an intervention study.
    Moghnieh R; Abdallah D; Awad L; Jadayel M; Haddad N; Tamim H; Zaiter A; Awwad DC; Sinno L; El-Hassan S; Lakkis R; Khalil R; Jisr T
    Ann Clin Microbiol Antimicrob; 2020 Aug; 19(1):35. PubMed ID: 32762758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
    Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
    Metan G; Alp E; Yildiz O; Percin D; Aygen B; Sumerkan B
    J Chemother; 2010 Apr; 22(2):110-4. PubMed ID: 20435570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.
    Curcio D; Fernández F; Cané A; Barcelona L; Stamboulian D
    Braz J Infect Dis; 2008 Jun; 12(3):198-201. PubMed ID: 18833403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
    Paluchowska P; Nowak P; Skalkowska M; Bjdak A
    Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
    Giammanco A; Calà C; Fasciana T; Dowzicky MJ
    mSphere; 2017; 2(1):. PubMed ID: 28124025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
    Amat T; Gutiérrez-Pizarraya A; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Torre-Giménez Á; Garnacho-Montero J; Cisneros JM; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24(6):630-634. PubMed ID: 28970161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial use of tigecycline in Argentina].
    Curcio D; Fernández F; Duret F
    Rev Chilena Infectol; 2007 Dec; 24(6):497-9. PubMed ID: 18180827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing OXA-23 type strains among carbapenem-resistant
    Altun Ş; Koçak Tufan Z; Altun B; Önde U; Kınıklı S; Demiröz AP
    Turk J Med Sci; 2016 Dec; 46(6):1894-1899. PubMed ID: 28081345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
    Song JY; Cheong HJ; Choi WS; Heo JY; Noh JY; Kim WJ
    J Med Microbiol; 2011 May; 60(Pt 5):605-611. PubMed ID: 21233298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.